Objective. To define the role of Toll-like receptors (TLR-2, TLR-4) and triggering receptor expressed on myeloid cells-1 (TREM-1) in pregnant human myometrium. Study Design. Expression of TLR-2 and -4 mRNA and protein and TREM-1 mRNA was quantified in human myometrial samples. Subsequently, we investigated the effect of medroxyprogesterone acetate (MPA) as a functional inhibitor of the TLR agonist lipopolysaccharide (LPS). Results. Messenger RNA expression of TLR-2 and -4 was significantly higher in myometrium at term compared with preterm (P = .009 and .016, respectively). Toll-like receptor-2 protein expression was significantly higher during labor (P = .002) compared with nonlaboring samples. Triggering receptor expressed on myeloid cells-1 mRNA expression was increased in both myometrium and cervix after labor at term (P < .05). Medroxyprogesterone acetate significantly suppressed LPS-induced production of interleukin 1b (IL-1b), IL-6, and IL-8 in vitro (P < .05). Conclusion. Toll-like receptors 2and 4 and TREM-1 are expressed in human myometrium and may play a role in the mechanism of labor at term, and their functional effects are inhibited by MPA.
Dod JM, Flenady VJ, Cincotta R., Crowther CAProgesterone for the prevention of preterm birth: a systematic review . Obstet Gynecol. 2008;112(1):127-134.
2.
Kelly RWInflammatory mediators and parturition. Rev Reprod . 1996;1(2):89-96.
3.
Thomson AJ, Telfer JF, Young A., et al. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod. 1999;14(1):229-236.
4.
Young A., Thomson A., Ledingham M., Jordan F., Greer I., Norman JEImmunolocalization of pro-inflammatory cytokines in myometrium, cervix and fetal membranes during human parturition at term. Biol Reprod . 2002;66(2):445-449.
5.
Osman I., Young A., Ledingham MA, et al. Leukocytes density and pro-inflammatory cytokines expression in human fetal membranes, deciduas, cervix and myometrium before and during labour at term. Mol Hum Reprod. 2003;9(1):41-45.
6.
Keski-Nisula L., Aalto ML, Katila ML, Kirkinen P.Intrauterine Inflammatio at term: a histopathologic study. Hum Pathol. 2000;31(7):841-846.
7.
Kelly RWInflammatory mediators and cervical ripening. J Reprod Immunol . 2002;57(1-2):217-224.
8.
Ledingham M. , Thomson A., Macara L., Young A., Greer I., Norman JEChanges in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition. Mol Hum Reprod. 2000;6(11):1041-1048.
9.
Allport VC, Pieber D., Slater DM, Newton R., White JO, Bennett PRHuman labour is associated with nuclear factor-kappa B activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal.’ Mol Hum Reprod. 2001;7(6):581-586.
10.
Romero R., Mazor M., Tartakovsky B.Systemic administration of interleukin-1 induces preterm parturition in mice . Am J Obstet Gynecol. 1991;165(4 pt 1):969-971.
Kim YM, Romero R., Chaiworapongsa T., et al. Toll-like receptor 2 and 4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol. 2004 ;191(4): 1346-1355.
15.
O’Brien M., Morrison JJ, Smith TJUpregulation of PSCDBP, TLR2, TWIST1, FLJ35382, EDNRB and RGS12 gene expression in human myometrium at labor. Reprod Sci. 2008;15(4):382-393.
16.
Wang H., Hirsch E.Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of Toll-like receptor 4. Biol Reprod. 2003;69(6):1957-1963.
17.
Lorenz E., Hallman M., Martilla R., Haataja R., Schwartz DAAssociation between the Asp 299 Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res. 2002;52(3):373-376.
18.
Tsan M., Gao B.Endogenous ligands of Toll-like receptors. J Leukoc Biol. 2004;76(3):514-519.
19.
Sato M., Sano H., Iwaki D., et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-α secretion are down-regulated by lung collection surfactant protein A. J Immunol. 2003;171(1):417-425.
20.
Condon JC, Jeyasuria P., Faust JM, Medelson C.Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci U S A. 2004;101(14):4978-4983.
21.
Leong AS-Y , Norman JE, Smith R.Vascular and myometrial changes in the human uterus at term. Reprod Sci. 2008;15(1):59-65.
22.
Kim CJ, Kim JS, Kim YM, et al. Fetal macrophages are not present in the myometrium of women with labor at term. Am J Obstet Gynecol. 2006 ;195(3):829-833.
23.
Bouchon A., Dietrich J., Colonna M.Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor on neutrophils and monocytes. J Immunol. 2000 ;164(10): 4991-4995.
24.
Klesney-Tait J., Turnbull IR, Colonna M.The TREM receptor family and signal integration . Nat Immunol. 2006 ;7(12):1266-1273.
25.
Netea MG, Azam T., Ferwerda G., Girardin SE, Kim S., Dinarello CATriggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J Leukoc Biol. 2006;80(6):1454-1461.
26.
Fortin CF, Lesur O., Fulop T.Effects of TREM-1 activation in human neutrophils: activation of signalling pathways, recruitment into lipid rafts and association with TLR4. Int Immunol. 2007;19(1):41-50.
27.
Ornatowska M., Azim AC, Wang X., et al. Functional genomics of silencing TREM-1 on TLR4 signalling in macrophages. Am J Physiol Lung Cell Mol Phyiol. 2007; 293(6):1377-1384.
28.
Ledingham MA , Thomson AJ, Jordan F., Young A., Crawford M., Norman JECell adhesion molecule expression in the cervix and myometrium during pregnancy and parturition . Obstet Gynecol . 2001;97(2):235-242.
29.
Romero R., Espinoza J., Kusanovic JP, et al. The preterm parturition syndrome. BJOG. 2006;113(suppl 3):17-42.
30.
Robin P., Boulven I., Desmyter C., Harbon S., Leiber D.ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells. Am J Physiol Cell Phyiol . 2002;283(1):251-260.
31.
Zhong M., Yang M., Sanborn BMExtracellular signal-regulated kinase ½ activation by myometrial oxytocin receptor involves Galpha (q) Gbetagamma and epidermal growth factor receptor tyrosine kinase activation. Endocrinology. 2003;144(7):2947-2956.
32.
Ohmichi M., Koike K., Kimura A., et al. Role of mitogenactivated protein kinase pathway in prostaglandin F2 alpha-induced rat puerperal uterine contraction. Endocrinology . 1997;138(8):3103-3111.
33.
Pahl HLActivators and target genes of Rel/NF-kappa B transcription factors . Oncogene. 1999;18(49):6853-6866.
34.
Chapman NR, Europe-Finner GN, Robson SCExpression and deoxyribonucleic acid-binding activity of the nuclear factor kappa B family in the human myometrium during pregnancy and labour . J Clin Endocrinol Metab. 2004;89(11): 5683-5693.
35.
Elliott CL, Allport VC, Loudon JA, Wu GD, Bennett PRNuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod . 2001;7(8):787-790.
36.
Ilievski V. , Lu SJ, Hirsch E.Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci. 2007;14(4):315-320.
37.
Janeway CA, Medzhitov R.Innate immune recognition. Annu Rev Immunol. 2002;20:197-216.
38.
Yamamoto M. , Sato S., Hemmi H.Role of adaptor TRIF in he MyD88-independent toll-like receptor signalling pathway. Science. 2003;301(5633):640-643.
39.
Takeda K., Akira S.TLR signalling pathways. Semin Immunol. 2004 ;16(1):3-9.
40.
Hsu L., Park JM, Zhang K., et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature. 2004;428(6980):341-345.
41.
Bouchon A., Facchetti F., Weigand MA, Colonna M.TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410(6832):1103-1107.
42.
Nathan C., Ding A.TERM-1: a new regulator of innate immunity in sepsis syndrome. Nat Med. 2001;7(5):530-532.
43.
Bleharski JR , Kiessler V., Buonsanti C., et al. A role for triggering receptor expressed on myeloid cells-1 in host defence during he early-induced and adaptive phases of the immune response. J Immunol. 2003;170(7):3812-3818.
44.
Knapp S., Gibot S., de Vose A., Versteeg HH, Colonna M., van der Poll T.Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Imunol . 2004;173(12):7131-7134.
45.
Gibot S., Kolopp-Sarda MN, Béné MC, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 2004;200(11):1419-1426.
46.
Cohen J.TREM-1 in sepsis. Lancet. 2001;358(9284):776-778.
47.
Colonna M., Facchetti F.TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis. 2003 ;187(suppl 2):397-401.
48.
Gibot S., Cravoisy A.Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res. 2004;2(3):181-187.
49.
Gibot S.The therapeutic potential of TREM-1 modulation in the treatment of sepsis and beyond. Curr Opin Investig Drugs. 2006 ;7(5):438-442.
50.
Gingras MC, Lapillonne H., Marglin JFTREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol. 2002;38(11): 817-824.
51.
Liu-Bryan R. , Terkeltaub R.Evil humors take their toll as innate immunity makes gouty joints TREM-ble . Arthritis Rheum. 2006;54(2):383-386.
52.
Koussoulas V., Vassiliou S., Demonakou M., et al. Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease. Eur J Gastroenterol Hepatol. 2006;18(4):375-379.
53.
Gibot S., Cravoisy A., Levy B., Bene MC, Faure G., Bollaert PESoluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350(5):451-458.
54.
Csapo A.Progesterone block. Am J Anat. 1956 ;98(2): 273-291.
55.
Meis PJ, Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348(24):2379-2385.
56.
American College of Obstetricians and Gynecologists.ACOG Committee Opinion. Use of Progesterone to reduce preterm birth. Obstet Gynecol. 2003;102(5 pt 1):1115-1116.
